Dr. Brian L. Burnette
Claim this profileSaint Vincent Hospital Cancer Center Green Bay
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
82 drugs studied
Area of expertise
1Cancer
Global LeaderStage III
Stage IV
Stage I
2Breast Cancer
HER2 positive
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Brian L. Burnette is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Bupropion
for Fatigue in Breast Cancer Survivors
This phase III trial studies how well bupropion works in reducing cancer related fatigue in cancer survivors. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving bupropion may improve cancer related fatigue in cancer survivors.
Recruiting1 award Phase 38 criteria
More about Brian L. Burnette
Clinical Trial Related4 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Brian L. Burnette has experience with
- Carboplatin
- Nivolumab
- Cisplatin
- Fluorouracil
- Paclitaxel
- Pembrolizumab
Breakdown of trials Brian L. Burnette has run
Cancer
Breast Cancer
Recurrence
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian L. Burnette specialize in?
Brian L. Burnette focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Brian L. Burnette currently recruiting for clinical trials?
Yes, Brian L. Burnette is currently recruiting for 15 clinical trials in Green Bay Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Brian L. Burnette has studied deeply?
Yes, Brian L. Burnette has studied treatments such as Carboplatin, Nivolumab, Cisplatin.
What is the best way to schedule an appointment with Brian L. Burnette?
Apply for one of the trials that Brian L. Burnette is conducting.
What is the office address of Brian L. Burnette?
The office of Brian L. Burnette is located at: Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin 54301 United States. This is the address for their practice at the Saint Vincent Hospital Cancer Center Green Bay.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.